TARS - Tarsus Pharmaceuticals GAAP EPS of -$0.24 beats by $0.48 revenue of $15.28M beats by $4.03M August, 11 2022 05:34 PM Tarsus Pharmaceuticals Inc. Tarsus Pharmaceuticals press release ( NASDAQ: TARS ): Q2 GAAP EPS of -$0.24 beats by $0.48 . Revenue of $15.28M (-30.6% Y/Y) beats by $4.03M . For further details see: Tarsus Pharmaceuticals GAAP EPS of -$0.24 beats by $0.48, revenue of $15.28M beats by $4.03M